URINARY LYSOSOMAL ENZYME EXCRETION AFTER RENAL ALLOTRANSPLANTATION

Three urinary lysosomal enzymes, β-glucuronidase (β-Gluc), β-galactosidase (β-Gal) and N-acetyl-β-d-glucosaminidase (NAG), were measured in twenty-one renal allograft recipients to evaluate their role in the diagnosis and prediction of rejection episodes, and in the prediction of eventual graft outcome. A fluorometric assay using methylumbelliferone substrates was used to measure the three enzymes in morning urine samples and enzymes activity was defined in terms of urine creatinine concentration. Urinary NAG levels increased significantly in 13 16 first rejection episodes and 4 4 instances of acute tubular necrosis and graft infraction. In 5 of the 16 first rejection episodes the NAG was predictive of the rejection. NAG was not useful in diagnosing second or subsequent rejections and β-Gluc and β-Gal were of little value in assessing any component of renal transplant pathology. As a prognostic index of eventual graft outcome, the peak urinary NAG was particularly encouraging. It correlated strongly with deterioration in graft function as time passed such that only 2 10 patients with peak NAG > 1400 Units had normal serum creatinines at 6 months post transplantation. Conversely 4 4 patients with peak NAG levels < 700 Units had normal serum creatinine at that time. In our series the measurement of urinary NAG was a useful adjunct to the diagnosis of first rejections but appears to be more valuable in predicting graft outcome. © 1979.